Cover Image

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach

The high incidences of COVID-19 cases are believed to be associated with high transmissibility rates, which emphasizes the need for the discovery of evidence-based antiviral therapies for curing the disease. The rationale of repurposing existing classes of antiviral small molecule therapeutics again...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sivakumar Gangadharan (Author), Jenifer Mallavarpu Ambrose (Author), Anusha Rajajagadeesan (Author), Malathi Kullappan (Author), Shankargouda Patil (Author), Sri Harshini Gandhamaneni (Author), Vishnu Priya Veeraraghavan (Author), Aruna Kumari Nakkella (Author), Alok Agarwal (Author), Selvaraj Jayaraman (Author), Krishna Mohan Surapaneni (Author)
Format:	Book
Published:	Elsevier, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021)

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
by: Sveva Pelliccia, et al.
Published: (2017)

Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
by: Quanjie Li, et al.
Published: (2021)

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
by: Purushothaman Indu, et al.
Published: (2020)

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
by: Mai E. Shoman, et al.
Published: (2022)

Thiolutin Derivatives as inhibitor of RNA-Dependent RNA Polymerase (RdRP) of Hepatitis C Virus: An In-silico Approach
by: Muhammad Imran Qadir, et al.
Published: (2018)

Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach
by: Satabdi Saha, et al.
Published: (2021)

Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase.
by: Hideaki Shimizu, et al.
Published: (2019)

RNA Polymerase II Activity of Type 3 Pol III Promoters
by: Zongliang Gao, et al.
Published: (2018)

Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach
by: Galiano V, et al.
Published: (2016)

Compatibility and Fidelity of Mirror-Image Thymidine in Transcription Events by T7 RNA Polymerase
by: Qingju Liu, et al.
Published: (2020)

SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review
by: Yusuf Muhammed, et al.
Published: (2021)

Awareness and knowledge of oral manifestations in cardiovascular diseases among the general public
by: S Shreenidhi, et al.
Published: (2022)

Identification of potential inhibitors of Zika virus NS5 RNA-dependent RNA polymerase through virtual screening and molecular dynamic simulations
by: Noreen, et al.
Published: (2020)

Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients
by: Carmen Gratteri, et al.
Published: (2023)

Characterizing intergenic transcription at RNA polymerase II binding sites in normal and cancer tissues
by: Pierre de Langen, et al.
Published: (2023)

Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3)
by: Selvaraj Jayaraman, et al.
Published: (2023)

Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico
by: Jameel M. Abduljalil, et al.
Published: (2023)

Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis.
by: Louise E Kerry, et al.
Published: (2017)

An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation
by: Alessia Caputo, et al.
Published: (2022)

ML-Based Screening of miRNA Inhibitors and Intervention of lncRNA/miRNA/mRNA Axis in Oncogenic KRAS-Associated Colorectal Cancer
by: Prasanna Srinivasan Ramalingam, et al.
Published: (2024)

Template Entrance Channel as Possible Allosteric Inhibition and Resistance Site for Quinolines Tricyclic Derivatives in RNA Dependent RNA Polymerase of Bovine Viral Diarrhea Virus
by: Mitul Srivastava, et al.
Published: (2023)

Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations
by: Faez Iqbal Khan, et al.
Published: (2021)

The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study
by: César A. Zapata-Acevedo, et al.
Published: (2022)

Chitosan loaded RNA polymerase inhibitor nanoparticles increased attenuation in toxin release from Streptococcus pneumonia
by: Fulwah Yahya Alqahtani, et al.
Published: (2023)

Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations
by: Frontiers Production Office
Published: (2022)

Unlocking the potential of beta sitosterol: Augmenting the suppression of oral cancer cells through extrinsic and intrinsic signalling mechanisms
by: Selvaraj Jayaraman, et al.
Published: (2023)

The Circular RNA-miRNA Axis: A Special RNA Signature Regulatory Transcriptome as a Potential Biomarker for OSCC
by: Ramanathan Saikishore, et al.
Published: (2020)

Discovery of SARS-CoV-2 RNA-dependent-RNA-polymerase (RdRp) Inhibitor from Sambiloto (Andrographis paniculata) Based on Molecular Docking and ADMET Prediction Approach
by: Dina Ahsana, et al.
Published: (2022)

Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance Mutants
by: Muhammad Arba, et al.
Published: (2022)

The Role of RNA Polymerase II Contiguity and Long-Range Interactions in the Regulation of Gene Expression in Human Pluripotent Stem Cells
by: Livia Eiselleova, et al.
Published: (2019)

Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study
by: Suhaina Supian, et al.
Published: (2022)

Regulator Non-coding RNAs: miRNA, siRNA, piRNA, lncRNA, circRNA
by: Ertan Altayli
Published: (2020)

DNA-PK regulates HIV transcription and latency by supporting the activity of RNA polymerase II and the recruitment of transcription machinery at HIV LTR
by: M. Tyagi, et al.
Published: (2017)

The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in <i>Staphylococcus aureus</i>
by: Jan Balansky, et al.
Published: (2022)

Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation
by: Shahkaar Aziz, et al.
Published: (2023)

Comparative study of male and female human hair: A microscopic analysis
by: S Sneha Harshini, et al.
Published: (2022)

Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach
by: Hisham N. Altayb
Published: (2022)

Crosstalk of mRNA, miRNA, lncRNA, and circRNA and Their Regulatory Pattern in Pulmonary Fibrosis
by: Changye Li, et al.
Published: (2019)

India's first successful surrogate birth after percutaneous oocyte retrieval following modified radical hysterectomy and right ovarian transposition to the anterior abdominal wall
by: Priya Selvaraj, et al.
Published: (2019)